Methicillin-resistant Staphylococcus aureus


Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that causes an infection resistant to common antibiotics, including methicillin, amoxicillin, and penicillin.[1]

Signs and symptoms[edit]
Most MRSA infections occur on the skin and are mild, presenting as red, swollen, and painful areas, often resembling pimples or spider bites. However, MRSA infections can also be serious or life-threatening, manifesting as pneumonia, bloodstream infections, or bone and joint infections, and can be difficult to treat.[2]
Risk factors[edit]
MRSA infections usually occur in people with weakened immune systems who are in hospitals, nursing homes, or other healthcare centers. They can also occur in healthy people who have skin-to-skin contact with others, such as childcare workers, team athletes, and people who live in crowded conditions. Risk factors include recent hospitalization, invasive procedures, residence in long-term care facilities, and close contact with someone who has MRSA.[3]
Diagnosis[edit]
Diagnosis of MRSA infections typically involves taking a sample from the site of infection and performing a culture and antibiotic susceptibility testing to identify the bacteria and determine its resistance to antibiotics.[4]
Prevention[edit]
Prevention strategies for MRSA infections include practicing good hand hygiene, maintaining clean environments, using contact precautions when interacting with infected individuals, and the judicious use of antibiotics to prevent the development of resistance. In healthcare settings, proper infection control measures are essential to minimize the spread of MRSA.[5]
Treatment[edit]
Treatment of MRSA infections typically involves the use of antibiotics that are still effective against the resistant bacteria, such as vancomycin, daptomycin, or linezolid. In some cases, surgical intervention may be required to drain abscesses or debride infected tissue. The choice of treatment depends on the severity of the infection and the patient's overall health.[6]
Prognosis[edit]
The prognosis of MRSA infections varies depending on the severity of the infection and the patient's overall health. Mild skin infections may resolve with appropriate antibiotic treatment, while more severe infections, such as bloodstream infections or pneumonia, may have a higher risk of complications and mortality.[7]
Epidemiology[edit]
The prevalence of MRSA infections varies by region and depends on local antibiotic resistance patterns. In some areas, MRSA accounts for a significant proportion of Staphylococcus aureus infections, while in others, the prevalence may be lower. Both hospital-associated MRSA (HA-MRSA) and community-associated MRSA (CA-MRSA) contribute to the overall burden of disease.[8]
References[edit]
- ↑ Methicillin-resistant Staphylococcus aureus (MRSA)(link). Centers for Disease Control and Prevention.Accessed 2023-05-05.
- ↑ Methicillin-resistant Staphylococcus aureus (MRSA) Infections(link). Mayo Clinic.Accessed 2023-05-05.
- ↑ MRSA: Understand your risk and how to prevent infection(link). Mayo Clinic.Accessed 2023-05-05.
- ↑ Methicillin-resistant Staphylococcus aureus (MRSA) Infections: Diagnosis & treatment(link). Mayo Clinic.Accessed 2023-05-05.
- ↑ MRSA: Prevention. Centers for Disease Control and Prevention.Accessed 2023-05-05.
- ↑ Methicillin-resistant Staphylococcus aureus (MRSA) Infections: Diagnosis & treatment(link). Mayo Clinic.Accessed 2023-05-05.
- ↑ MRSA: Prognosis(link). Medscape.Accessed 2023-05-05.
- ↑ MRSA: Epidemiology. World Health Organization.Accessed 2023-05-05.
* Firmicutes (low-G+C) Infectious diseases
|
||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
